Articles

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Kim BK, Hong SJ, Lee YJ, et al.

Journal: 

Lancet

First published: July 30, 2022  DOI: 10.1016/S0140-6736(22)00916-3

This month our featured article is on the RACING trial, which compares the efficacy and safety of combination therapy of ezetimibe and moderate-intensity statin with monotherapy of high-intensity statin in patients with ASCVD.